Neuropsych Schizo

Embed Size (px)

DESCRIPTION

NOTES

Citation preview

  • 5/19/2018 Neuropsych Schizo

    1/29

    Psychosis

    A symptom of severe psychiatric and non-

    psychiatric (medical) disorders that may be short

    lived or chronic

    It is often misunderstood

    The individual suffers a break in reality that

    influences all aspects of their life

  • 5/19/2018 Neuropsych Schizo

    2/29

    Differential Diagnosis of

    PsychosisPrescription medications causing symptoms-anticholinergic medications

    Illicit drugsintoxication from

    methamphetamines, cocaine, PCP,hallucinogens, or withdrawal from alcohol, orbenzodiazapenes - xanax, ativan

    Medical conditions like seizure, CNS infections,

    neurosyphilis, brain tumors

    Metabolic abnormalitiesthyroid disease,nutritional deficiencies

  • 5/19/2018 Neuropsych Schizo

    3/29

    Definition of Psychosis:

    Mental StatusBreak from reality evidenced by delusions,hallucinations, illusions, disordered thinking, loss

    of ego boundaries, or failed reality testing

    Affects thought contentor thought process

    A symptom of various disorders, but not a

    disorder in itself

    Lifetime prevalence of 3% in the US

  • 5/19/2018 Neuropsych Schizo

    4/29

    On the mental status

    exam: Thought ContentDelusions: fixed, false beliefs based on anincorrect reference about an external reality that

    fail to correct with reasoning & are inconsistent

    with patients education/cultureTypes include bizarre, delusional jealousy,

    erotomanic, grandiose, persecutory, somatic, of

    being controlled, thought broadcasting, thought

    insertion

    Ideas of reference: words or actions that have

    personal, special meaning but not full delusions

  • 5/19/2018 Neuropsych Schizo

    5/29

    On the mental status

    exam: Distorted

    perceptionsHallucinations: a sensory perception that has thecompelling sense of reality of a true perception

    but that occurs without external stimulation of the

    relevant sensory organ.May or may not have insight

    Mood congruent versus incongruent

    Illusions: actual external stimulus is misperceivedor misinterpreted

  • 5/19/2018 Neuropsych Schizo

    6/29

    What about during

    Dreams?Hypnagogic: when falling asleepHypnopompic: when awakening

  • 5/19/2018 Neuropsych Schizo

    7/29

    Illogical Thought Process

    CircumstantialityTangentiality

    Derailment

    Loose associations

    Thought blocking

    Neologismsmade up words

  • 5/19/2018 Neuropsych Schizo

    8/29

    Schizophrenia

    Serious and lifelong mental disorder

    Affects 1% of population

    Men >Women

    Onset: Men 18-25, women 25-mid 30s

    Urban born > rural born

    Striking disturbances in mental functioning

    Positive & negative signs and symptoms

    Disruption in experience of reality

  • 5/19/2018 Neuropsych Schizo

    9/29

    Schizophrenia

    Functionally impaired patients with at least 2

    characteristic symptoms (delusions,

    hallucinations, disorganized or catatonic

    behavior, or negative symptoms) with effectslasting at least 6 months.

  • 5/19/2018 Neuropsych Schizo

    10/29

    Positive symptoms

    an excess or distortion of normal functions

    Delusions, hallucinations

    Disorganized speech

    Catatonic behavior: motoric immobility, excessive

    motor activity, extreme negativism, mutism,

    pecularities of voluntary movement, echolalia

    Disorganized thinking (formal thought disorder)

    that impairs effective communication

  • 5/19/2018 Neuropsych Schizo

    11/29

    Negative Symptoms

    A diminution or loss of normal function

    Decreased emotional expressivity (affective

    flattening)

    Restricted speech fluency

    Alogiarestricted thought production

    Avolitiondecreased goal directed behavior

  • 5/19/2018 Neuropsych Schizo

    12/29

    Dopamine Hypothesis

    Thought that schizophrenia is by product of

    dopamine dysregulation

    Evidence from work in 1960s

    Administering Dopamine agonists

    amphetamine, produces symptoms like

    schizophrenia

    Most important Dopamine receptor is D2

  • 5/19/2018 Neuropsych Schizo

    13/29

    Neuroimaging and

    DopamineRelated to dopaminergic toneNewer hypothesis states the there is a hyper-

    dopamine state in the nigrastriatal D2 system

    that causes the positive symptoms & hypo-dopamine state in prefrontal D1 system with

    negative symptoms (cognitive problems)

  • 5/19/2018 Neuropsych Schizo

    14/29

  • 5/19/2018 Neuropsych Schizo

    15/29

  • 5/19/2018 Neuropsych Schizo

    16/29

    Limitations

    Dopamine hypothesis does not account for

    negative symptoms

    Dopamine blockers (antipsychotics) not effective

    in treating negative symptoms

    Dopamine agonists do not induce negative

    symptoms

  • 5/19/2018 Neuropsych Schizo

    17/29

    Glutamate

    May be associated with pathophysiology of

    schizophrenia

    People intoxicated with glutamate receptor

    agonists (PCP, ketamine) exhibit behavioralsigns like schizophreniaincluding positive &

    negative symptoms

    These drugs bind to the NMDA class of glutmate

    receptors

  • 5/19/2018 Neuropsych Schizo

    18/29

    GABA

    The effects of NMDA antagonists thought to be meditatedthrough GABA release

    NMDA receptors are found on GABAergic inhibitoryinterneurons

    Activating NMDA receptors causes increased GABAreleasesuppression of glutmate release

    In schizphrenia: binding of antagonist on NMDA receptoron GABA inhibitory receptor causes increasedglutamatergic state which is thought to cause symptoms of

    psychosis

    Higher order cognitive deficits in schizophrenia thought tobe linked to GABA dysregulation

  • 5/19/2018 Neuropsych Schizo

    19/29

    Antipsychotics

    Typicals: Older, Motor side effects, more potent

    Atypicals: Newer, metabolic side effects, lesspotent

  • 5/19/2018 Neuropsych Schizo

    20/29

    Typical Antipsychotics

    Haldol

    Developed in the 1950s

    Was the most widely used antipsychotic for

    schizophreniaIncreases neuronal activity throughout the basal

    ganglia

    No linear relationship between dose and

    antipsychotic action

  • 5/19/2018 Neuropsych Schizo

    21/29

    Atypicals

    Risperdone: higher risk of EPS than other

    atypicals (especially akathesia) & dose

    dependent. Weight gain, and prolactin elevation

    Olanzapine (Zyprexa): there is no increasedDopamine blockade after a certain dose, very

    sedating, significant weight gain

    Quetiapine (seroquel): Low EPS incidence, need

    very high doses to get D2 blockade, otherwise

    mostly sedation. Associated with hypotension

  • 5/19/2018 Neuropsych Schizo

    22/29

    Atypicals

    Aripiprazole (Abilify): clinically less effective for

    positive symptoms, lower risk of weight gain or

    EPS

    Ziprasidone (Geodon): clinically less effective forpositive symptoms, can have cardiac side effects

    Clozapine: effective in otherwise poorly

    responsive patients, requires strict monitoring

    because of blood count effects, not associated

    with TD

  • 5/19/2018 Neuropsych Schizo

    23/29

    D2 Receptor Affinities

    Receptor Seroquel Zyprexa Risperda

    l

    Abilify Haldol

    D2 + ++ +++ ++++ ++++

  • 5/19/2018 Neuropsych Schizo

    24/29

    Neurotransmitter Location of

    Synthesis

    Associated With

    Acetylcholine Basal Nucleus of

    Meynert

    Dopamine Substantia nigra Schizophrenia,addiction

    Norepinephrine Locus Ceruleus Depression, anxiety

    Serotonin Raphe Nuclei Depression, chronic

    pain

  • 5/19/2018 Neuropsych Schizo

    25/29

    Extrapyramidal side effects

    Directly related to D2 receptor blockade innigrostriatal pathway, balanced by excitatorycholinergic activity

    Acetylcholine works in conjunction withdopamine to produce movement.

    Smooth muscle control requires a balance ofdopamine & acetylcholine

    High potency, typical antipsychotics > lowpotency, typical antipsychotics > modern, atypicalantipsychotics at modest doses

  • 5/19/2018 Neuropsych Schizo

    26/29

    Takeaway Point

    In psychosis, Dopamine INCREASED

    Antipsychotic medications DECREASEdopamine

    Side effects of antipsychotic medications cancause DOPAMINE DEPLETION, & movementdysfunction (like Parkinsons disease, which is amovement disorder)

    To treat side effects, we use medications thatDECREASE acetylcholine (which effectivelyINCREASES Dopamine & restores balance)

  • 5/19/2018 Neuropsych Schizo

    27/29

    EPS symptom

    Acute dystonia Intermittent but

    sustained muscle

    spasms leading toinvoluntary

    movements

    Treated with

    anticholinergic

    medication in IV form

    Akathesia Sensation of motor

    restlessness

    associated with a

    strong desire to move

    lower extremity

    Treated with beta

    blocker

    Parkinsonism Rigidity, bradykinesia,

    tremor, masked

    facies, shuffling gait

    Treated with

    anticholinergic

    medication

    Tardive dyskinesia Movement disorderinvolving involuntary

    movements of mouth,

    tongue and upper

    extremities after

    chronic antipsychotic

    use

    Treated withclozapine, reducing

    antipsychotic dose

  • 5/19/2018 Neuropsych Schizo

    28/29

    Video of Bipolar &

    schizophrenia

  • 5/19/2018 Neuropsych Schizo

    29/29

    References

    The American Psychiatric Publishing Textbook of

    Psychiatry, 5thedition

    GabbardsTreatment of Psychiatric Disorders, 4th

    edition